Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...

The deal expands the local firm’s footprint as Quest exits market. #NewsismyBusiness - Stay updated with the latest Puerto Rico business news, economy insights, finance, retail, tourism, and more from ...

Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest Diagnostics, a leading provider of diagnostic information services, to make ...

Quest Diagnostics (NYSE:DGX) is partnering with Guardant Health to offer Shield, an FDA-approved blood test for colorectal cancer screening, across its nationwide network. The agreement expands access ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Shield™ by Guardant blood-based screening test is now widely accessible for physician order through ...

The 164 positive tests the state has collected since last fall likely represent a fraction of the people exposed to high PFAS levels.

Quest Diagnostics posts strong gains from physician and hospital channels while advancing AI-powered solutions.

A new study conducted by Washington University School of Medicine in St. Louis researchers found that a single blood test could predict when someone is likely to develop Alzheimer’s disease. The study ...

Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...

Researchers developed a "clock" model that based on a single blood test can estimate Alzheimer's symptom onset in cognitively unimpaired adults. The model predicted ...

Blood tests that detect a protein involved in Alzheimer’s disease could help predict the age at which the disease may strike people long before they develop symptoms, according to a new study. But ...

Researchers at Washington University School of Medicine in St. Louis have developed a method to predict when someone is likely to develop symptoms of Alzheimer's disease using a single blood test. In ...